John Snyder

ClearLight Biotechnologies LLC develops and commercializes tissue clearing technology. It provides innovative technologies to improve the diagnosis and treatment of diseases with an initial focus in oncology. The firm's technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The company was founded by Karl Deisseroth in 2014 and is headquartered in Mountain View, CA.

ClearLight Biotechnologies LLC develops and commercializes tissue clearing technology. It provides innovative technologies to improve the diagnosis and treatment of diseases with an initial focus in oncology. The firm's technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The company was founded by Karl Deisseroth in 2014 and is headquartered in Mountain View, CA.

ClearLight Biotechnologies LLC develops and commercializes tissue clearing technology. It provides innovative technologies to improve the diagnosis and treatment of diseases with an initial focus in oncology. The firm's technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The company was founded by Karl Deisseroth in 2014 and is headquartered in Mountain View, CA.